Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Myron David Kor who wrote (1859)	1/19/1998 11:27:00 PM
From: Cosmo Daisey	Read Replies (2) \| Respond to of 7041

MDK, The fraudulent patent application may have included work done by Dr. Balbir S. Bohgal. Dr.Bohgal served as Zonagen's Director of Immunology and he was probably doing research that has been included in the application as a basis for the patent. If he disagrees with the discovery stated in the patent application then perhaps he is concerned that his good name will be damaged by the application. I don't think he is trying to defend the patent system, just his name. A fraudulent patent is a patent that doesn't include any new discovery or claims discovery of a previously patented point of invention or discovery. Cosmo